These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 35006033

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Magnetic resonance imaging criteria of immune checkpoint inhibitor-induced hypophysitis.
    Nada A, Bhat R, Cousins J.
    Curr Probl Cancer; 2021 Feb; 45(1):100644. PubMed ID: 32888700
    [Abstract] [Full Text] [Related]

  • 3. Recovery from secondary adrenal insufficiency in a patient with immune checkpoint inhibitor therapy induced hypophysitis.
    Thapi S, Leiter A, Galsky M, Gallagher EJ.
    J Immunother Cancer; 2019 Sep 12; 7(1):248. PubMed ID: 31511065
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Autoimmune hypophysitis secondary to therapy with immune checkpoint inhibitors: Four cases describing the clinical heterogeneity of central endocrine dysfunction.
    Hartmann A, Paparoupa M, Volkmer BG, Rompel R, Wittig A, Schuppert F.
    J Oncol Pharm Pract; 2020 Oct 12; 26(7):1774-1779. PubMed ID: 32164491
    [Abstract] [Full Text] [Related]

  • 6. [A Case of Metachronous Occurrence of Interstitial Pneumonitis and Hypophysitis Following Nivolumab Plus Ipilimumab for Metastatic Renal Cell Carcinoma].
    Hayase T, Washino S, Mayumi S, Yazaki K, Nakamura Y, Oshima M, Konishi T, Saito K, Miyagawa T.
    Hinyokika Kiyo; 2021 Jun 12; 67(6):239-243. PubMed ID: 34265899
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The association of hypophysitis with immune checkpoint inhibitors use: Gaining insight through the FDA pharmacovigilance database.
    Tang Q, Han Y, Song M, Peng J, Zhang M, Ren X, Sun H.
    Medicine (Baltimore); 2024 Mar 29; 103(13):e37587. PubMed ID: 38552079
    [Abstract] [Full Text] [Related]

  • 11. Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma.
    Okano Y, Satoh T, Horiguchi K, Toyoda M, Osaki A, Matsumoto S, Tomaru T, Nakajima Y, Ishii S, Ozawa A, Shibusawa N, Shimada T, Higuchi T, Chikamatsu K, Yamada M.
    Endocr J; 2016 Oct 29; 63(10):905-912. PubMed ID: 27440480
    [Abstract] [Full Text] [Related]

  • 12. Checkpoint Inhibitor-Associated Hypophysitis.
    Chang LS, Yialamas MA.
    J Gen Intern Med; 2018 Jan 29; 33(1):125-127. PubMed ID: 28770379
    [No Abstract] [Full Text] [Related]

  • 13. A Case of Metastatic Fumarate Hydratase-Deficient-like Renal Cell Carcinoma Successfully Managed by Ipilimumab plus Nivolumab.
    Sekito T, Takamoto A, Kobayashi Y, Mitsui M, Watari S, Kubota R, Sadahira T, Iwata T, Nishimura S, Edamura K, Sako T, Araki M, Watanabe M, Watanabe T, Shibata R, Ennishi D, Nasu Y.
    Acta Med Okayama; 2021 Jun 29; 75(3):397-402. PubMed ID: 34176946
    [Abstract] [Full Text] [Related]

  • 14. Fulminant ACTH decrease following diabetic ketoacidosis induced by immune checkpoint inhibitor combination therapy with nivolumab and ipilimumab: A case report.
    Iesaka H, Kameda H, Miya A, Nomoto H, Cho KY, Nakamura A, Abe T, Shinohara N, Atsumi T.
    Medicine (Baltimore); 2023 Dec 22; 102(51):e36664. PubMed ID: 38134115
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hypophysitis induced by ipilimumab and nivolumab combination therapy for advanced renal cell carcinoma: A case report.
    Motonaga A, Nakanishi S, Tanaka K, Nishida S, Izumi K, Saito S.
    Urol Case Rep; 2021 Sep 22; 38():101661. PubMed ID: 33868946
    [Abstract] [Full Text] [Related]

  • 18. Fatal fulminant hepatitis induced by combined ipilimumab and nivolumab therapy despite favorable histologic response and confirmed by autopsy in a patient with clear cell renal cell carcinoma.
    Kubo T, Sugawara T, Shinkawa T, Kurisu T, Kouzen N, Tanaka T, Fukuta F, Yamasaki K, Sugita S, Matsuo K, Morita R, Hirohashi Y, Tsukahara T, Kanaseki T, Hasegawa T, Masumori N, Torigoe T.
    Immunol Med; 2021 Jun 22; 44(2):136-141. PubMed ID: 32634346
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Onset of fulminant type 1 diabetes mellitus following hypophysitis after discontinuation of combined immunotherapy. A case report.
    Boswell L, Casals G, Blanco J, Jiménez A, Aya F, de Hollanda A, Halperin I, Arance AM, Mora M, Hanzu FA.
    J Diabetes Investig; 2021 Dec 22; 12(12):2263-2266. PubMed ID: 34048145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.